Literature DB >> 17285001

Free fatty acids and insulin resistance.

Jacques Delarue1, Christophe Magnan.   

Abstract

PURPOSE OF REVIEW: Dysregulation of free fatty acid metabolism is a key event responsible for insulin resistance and type 2 diabetes. According to the glucose-fatty acid cycle of Randle, preferential oxidation of free fatty acids over glucose plays a major role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. However, other mechanisms are now described to explain the molecular basis of insulin resistance. RECENT
FINDINGS: Recent studies have suggested that local accumulation of fat metabolites such as ceramides, diacylglycerol or acyl-CoA, inside skeletal muscle and liver, may activate a serine kinase cascade leading to defects in insulin signalling and glucose transport. Inflammation and oxidative stress are also potent mechanisms which could lead to a state of insulin resistance. Finally, modulation of transcription by free fatty acids through their binding to peroxisome proliferator-activated receptors could also contribute to impaired glucose metabolism.
SUMMARY: The increase in free fatty acid flux resulting from increased lipolysis secondary to adipose-tissue insulin resistance induces or aggravates insulin resistance in liver and muscle through direct or indirect (from triglyceride deposits) generation of metabolites, altering the insulin signalling pathway. Alleviating the excess of free fatty acids is a target for the treatment of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285001     DOI: 10.1097/MCO.0b013e328042ba90

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  154 in total

1.  Emerging adenosine receptor agonists: an update.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Expert Opin Emerg Drugs       Date:  2011-12-07       Impact factor: 4.191

2.  A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.

Authors:  Kirstin F Barnhart; Dawn R Christianson; Patrick W Hanley; Wouter H P Driessen; Bruce J Bernacky; Wallace B Baze; Sijin Wen; Mei Tian; Jingfei Ma; Mikhail G Kolonin; Pradip K Saha; Kim-Anh Do; James F Hulvat; Juri G Gelovani; Lawrence Chan; Wadih Arap; Renata Pasqualini
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

Review 3.  Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.

Authors:  Fei Yin; Harsh Sancheti; Zhigang Liu; Enrique Cadenas
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

Review 4.  [Disturbed sleep as risk factor for metabolic syndrome].

Authors:  S M Schmid; B Schultes
Journal:  Internist (Berl)       Date:  2011-04       Impact factor: 0.743

5.  Nonesterified fatty acids and risk of sudden cardiac death in older adults.

Authors:  Luc Djoussé; Mary L Biggs; Joachim H Ix; Jorge R Kizer; Rozenn N Lemaitre; Nona Sotoodehnia; Susan J Zieman; Dariush Mozaffarian; Russell P Tracy; Kenneth J Mukamal; David S Siscovick
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-26

6.  Metabolic stress signaling mediated by mixed-lineage kinases.

Authors:  Anja Jaeschke; Roger J Davis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

7.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

8.  Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.

Authors:  Débora Luiza Quintilhano; Daniele Romani Miksza; Winny Beatriz de Souza Galia; Mahira Oliveira Ramalho Costa Ramalho; Camila Ferraz Lucena; Maíra Mello Rezende Valle; Maria Fernanda Rodrigues Graciano; Helenir Medri de Souza; Gisele Lopes Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

Review 10.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.